Short Squeeze Stocks: PROG, SAVA and 3 Others Experts Think Are

Short Squeeze Stocks: PROG, SAVA and 3 Others Experts Think Are Ready to Pop; 

https://investorplace.com/2021/11/short-squeeze-stocks-prog-sava-and-3-others-experts-think-are-ready-to-pop/?

Cassava Sciences (NASDAQ:SAVA). This stock has been garnering considerable coverage throughout recent weeks as shares have skyrocketed by staggering numbers. Although, like PROG, it’s begun this week in the red, shares are up 90% for the past week and almost 75% for the past month. The biotech company has been making progress with its new Alzheimer’s treatment drug. And despite some reports that have called it into question, most recent news for Cassava has been positive. However, it’s not hard to see how these types of numbers would make it a tempting short candidate. Fintel scores it at 92.06 and notes that short interest has increased b 260% throughout the course of 2021, moving from 2.6 million shares in February to a high of 9.4 million in October.

所有跟帖： 

• SAVA上榜 -nyg- ♀ (0 bytes) () 11/08/2021 postreply 17:06:33

• Cassava Sciences Stock's Hypothesis Raises Doubts -flyhigh135- ♀ (342 bytes) () 11/08/2021 postreply 19:15:40